Lauren is responsible for covering oncology research and diligence. Prior to joining RTW, Lauren was on the investment team at Solasta Ventures and subsequently, at Syno Capital, where she held roles in sourcing, diligence, and leading investments in venture stage opportunities in therapeutics.
Lauren received her PhD in Oncology from the Johns Hopkins University School of Medicine, where she focused on the preclinical and clinical development of small molecules in acute myeloid leukemia including Xospata and Vanflyta. Prior to these roles, Lauren started off her career as a bench scientist at Onyx Pharmaceuticals and Amgen in South San Francisco, where she led the preclinical studies on immunoprotease inhibitors. She also holds BA and BS degrees in Immunology and Economics from the University of California, Berkeley.
I feel privileged to help accelerate the translation of scientific dreams into therapeutic realities for patients everywhere.